Showing 5,821 - 5,840 results of 16,418 for search '"Therapy"', query time: 0.10s Refine Results
  1. 5821
  2. 5822
  3. 5823
  4. 5824
  5. 5825
  6. 5826
  7. 5827
  8. 5828
  9. 5829

    Availability in ECMO Reduces the Failure to Rescue in Patients With Pulmonary Embolism After Major Surgery: A Nationwide Analysis of 2.4 Million Cases by Johannes Diers, MD, Nikolas Baumann, MD, Philip Baum, MD, Konstantin L. Uttinger, MD, Johanna C. Wagner, MD, Peter Kranke, MD, Patrick Meybohm, MD, Christoph-Thomas Germer, MD, Armin Wiegering, MD

    Published 2024-06-01
    “…Postoperative pulmonary embolism (PE) is a rare but potentially life-threatening complication, which can be treated with extracorporeal membrane oxygenation (ECMO) therapy, a novel therapy option for acute cardiorespiratory failure. …”
    Get full text
    Article
  10. 5830

    Design and Development of a Web‐Based Registry for Outpatient Rehabilitation: A Delphi Multi‐Disciplinary, Expert Consensus Study by Seyyedeh Fatemeh Mousavi Baigi, Masoumeh Sarbaz, Davood Sobhani‐Rad, Salman Nazary‐Moghadam, Javad Heravian Shandiz, Kosar Ghaddaripouri, Reyhane Norouzi Aval, Khalil Kimiafar

    Published 2025-01-01
    “…ABSTRACT Background and Aims The goal of this research was to create a minimum data set (MDS) and design a web‐based registry for outpatient rehabilitation, focusing on four disciplines: speech therapy, audiology, optometry, and physical therapy. …”
    Get full text
    Article
  11. 5831

    Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men by Feng-fei Li, Bing-li Liu, Hong-hong Zhu, Ting Li, Wen-li Zhang, Xiao-fei Su, Jin-dan Wu, Xue-qin Wang, Ning Xu, Wei-Nan Yu, Qun Yuan, Guan-cheng Qi, Lei Ye, Kok-Onn Lee, Jian-hua Ma

    Published 2017-01-01
    “…Each group was further divided into male and female patients. CSII therapy was maintained for 3 weeks after the glycemic target was reached. …”
    Get full text
    Article
  12. 5832

    The “real life” efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP by Nicholas J. Campion, Jonas Brugger, Aldine Tu, Victoria Stanek, Faris F. Brkic, Tina J. Bartosik, David T. Liu, Bruna S. Hoehl, Katharina Gangl, Julia Eckl-Dorna, Sven Schneider

    Published 2023-09-01
    “…Finally the model showed that neither oral nor nasal steroids influenced the rate of response to dupilumab therapy. Conclusions Polyp size at the initiation of dupilumab therapy and whether patients continue to take steroid therapy does not appear to influence effectiveness of dupilumab treatment.…”
    Get full text
    Article
  13. 5833
  14. 5834

    Injectable Tumoricidal Neural Stem Cell-Laden Hydrogel for Treatment of Glioblastoma Multiforme—An In Vivo Safety, Persistence, and Efficacy Study by Jasmine L. King, Alain Valdivia, Shawn D. Hingtgen, S. Rahima Benhabbour

    Published 2024-12-01
    “…Despite efforts to advance treatment, GBM remains treatment resistant and inevitably progresses after first-line therapy. Induced neural stem cell (iNSC) therapy is a promising, personalized cell therapy approach that has been explored to circumvent challenges associated with the current GBM treatment. …”
    Get full text
    Article
  15. 5835

    Polyclonal Recipient nTregs Are Superior to Donor or Third-Party Tregs in the Induction of Transplantation Tolerance by Nina Pilat, Christoph Klaus, Karin Hock, Ulrike Baranyi, Lukas Unger, Benedikt Mahr, Andreas M. Farkas, Fritz Wrba, Thomas Wekerle

    Published 2015-01-01
    “…We have previously reported successful induction of chimerism and tolerance using cell therapy with recipient T regulatory cells (Tregs) to avoid cytotoxic recipient treatment. …”
    Get full text
    Article
  16. 5836
  17. 5837

    Transcatheter Arterial Chemoembolization Based on Hepatic Hemodynamics for Hepatocellular Carcinoma by Satoru Murata, Takahiko Mine, Tatsuo Ueda, Ken Nakazawa, Shiro Onozawa, Daisuke Yasui, Shin-ichiro Kumita

    Published 2013-01-01
    “…Patients with intermediate-stage HCC benefit from transcatheter arterial chemoembolization (TACE), and those diagnosed at an advanced stage receive sorafenib, a multikinase inhibitor, or conservative therapy. Most patients receive palliative or conservative therapy only, and approximately 50% of patients with HCC are candidates for systemic therapy. …”
    Get full text
    Article
  18. 5838

    Mesenchymal Stem Cells May Alleviate the Intervertebral Disc Degeneration by Reducing the Oxidative Stress in Nucleus Pulposus Cells by Yongzhao Zhao, Qian Xiang, Yunzhong Cheng, Jialiang Lin, Shuai Jiang, Weishi Li

    Published 2022-01-01
    “…Background. Stem cell therapy is a promising therapeutic modality for intervertebral disc degeneration (IDD). …”
    Get full text
    Article
  19. 5839

    Evaluating the effectiveness of adjuvant radiotherapy in addition to surgery versus surgery alone at improving oncologic outcomes for early stage buccal carcinoma: a systematic rev... by Corliss Ann Elizabeth Best, Alexandra Elizabeth Quimby, Brittany Ann Barbara Best, Dean Fergusson, Hussain Alsaffar

    Published 2019-12-01
    “…Abstract Objective To systematically review the evidence to evaluate oncologic outcomes for patients with early stage buccal squamous cell carcinoma treated with surgery versus surgery and adjuvant radiation therapy. Data sources Ovid MedLine, EMBASE, Google Scholar, PubMed. …”
    Get full text
    Article
  20. 5840

    Cardiac Effects of Thyrotropin Oversuppression with Levothyroxine in Young Women with Differentiated Thyroid Cancer by Kyung-Soon Hong, Jung-Woo Son, Ohk Hyun Ryu, Moon-Gi Choi, Ji Yeon Hong, Seong Jin Lee

    Published 2016-01-01
    “…This study shows that TSH suppression therapy in women with DTC may be safe with respect to cardiac functions and structures despite intermittent oversuppression of TSH during long-term suppressive therapy. …”
    Get full text
    Article